Brian Patrick Conlon

Brian Patrick Conlon

Auto-generated profile, based on publicly available information

Brian Patrick Conlon

Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 January 2015 in Nature
Verified
Journal Article
Closed access
PDF file
LLLosee L. Ling
Losee L. Ling
TSTanja Schneider
Tanja Schneider
APAaron J. Peoples
Aaron J. Peoples
ASAmy L. Spoering
Amy L. Spoering
IEIna Engels
Ina Engels
KLKim Lewis
Kim Lewis

18 April 2016 in Nature Microbiology
Verified
Journal Article
Open access
BCBrian P. Conlon
Brian P. Conlon
SRSarah E. Rowe
Sarah E. Rowe
AGAutumn Brown Gandt
Autumn Brown Gandt
ANAustin S. Nuxoll
Austin S. Nuxoll
NDNiles P. Donegan
Niles P. Donegan
KLKim Lewis
Kim Lewis
Persisters are dormant phenotypic variants of bacterial cells that are tolerant to killing by antibiotics(1). Persisters are associated with chronic infect

13 November 2013 in Nature
Verified
Journal Article
Closed access
PDF file
BCB. P. Conlon
B. P. Conlon
ENErnesto Nakayasu
Ernesto Nakayasu
LFL. E. Fleck
L. E. Fleck
MLM. D. LaFleur
M. D. LaFleur
VIV. M. Isabella
V. M. Isabella
KLK. Lewis
K. Lewis

9 December 2019 in Nature Microbiology
Verified
Journal Article
Closed access
PDF file
SRSarah E. Rowe
Sarah E. Rowe
NWNikki J. Wagner
Nikki J. Wagner
LLLupeng Li
Lupeng Li
JBJenna E. Beam
Jenna E. Beam
AWAlec D. Wilkinson
Alec D. Wilkinson
BCBrian P. Conlon
Brian P. Conlon


27 November 2017 in PLOS Biology
Verified
Journal Article
Open access
PDF file
LRLauren Radlinski
Lauren Radlinski
SRSarah E. Rowe
Sarah E. Rowe
LKLaurel B. Kartchner
Laurel B. Kartchner
RMRobert Maile
Robert Maile
BCBruce A. Cairns
Bruce A. Cairns
BCBrian P. Conlon
Brian P. Conlon
Chronic coinfections of Staphylococcus aureus and Pseudomonas aeruginosa frequently fail to respond to antibiotic treatment, leading to significant patient morbidity and mortality. Currently, the impact of interspecies interaction on S. aureus antibiotic susceptibility remains poorly understood. In this study, we utilize a panel of P. aeruginosa burn wound and cystic fibrosis (CF) lung isolates to demonstrate that P. aeruginosa alters S. aureus susceptibility to bactericidal antibiotics in a variable, strain-dependent manner and further identify 3 independent interactions responsible for antagonizing or potentiating antibiotic activity against S. aureus. We find that P. aeruginosa LasA endopeptidase potentiates lysis of S. aureus by vancomycin, rhamnolipids facilitate proton-motive force-independent tobramycin uptake, and 2-heptyl-4-hydroxyquinoline N-oxide (HQNO) induces multidrug tolerance in S. aureus through respiratory inhibition and reduction of cellular ATP. We find that the production of each of these factors varies between clinical isolates and corresponds to the capacity of each isolate to alter S. aureus antibiotic susceptibility. Furthermore, we demonstrate that vancomycin treatment of a S. aureus mouse burn infection is potentiated by the presence of a LasA-producing P. aeruginosa population. These findings demonstrate that antibiotic susceptibility is complex and dependent not only upon the genotype of the pathogen being targeted, but also on interactions with other microorganisms in the infection environment. Consideration of these interactions will improve the treatment of polymicrobial infections. Accurate prediction of antimicrobial efficacy is essential for successful treatment of a bacterial infection. While many studies have considered the impacts of genetically encoded mechanisms of resistance, nongenetic determinants of antibiotic susceptibility during infection remain poorly understood. Here we show that a single interspecies interaction between 2 human pathogens, S. aureus and P. aeruginosa, can completely transform the antibiotic susceptibility profile of S. aureus. Through multiple distinct mechanisms, P. aeruginosa can antagonize or potentiate the efficacy of multiple classes of antibiotics against S. aureus. We identify the exoproducts responsible for altering S. aureus susceptibility to antibiotic killing, and furthermore demonstrate that these compounds are produced at varying levels in P. aeruginosa clinical isolates, with dramatic repercussions for S. aureus antibiotic susceptibility. Finally, we use a mouse model of P. aeruginosa–S. aureus coinfection to demonstrate that the presence of P. aeruginosa significantly alters the outcome of S. aureus antibiotic therapy in a host. These findings indicate that the efficacy of antibiotic treatment in polymicrobial infection is determined at the community level, with interspecies interaction playing an important and previously unappreciated role.